C2 PHARMA receives CEP approval from EDQM for oxybuprocaine hydrochloride: Cork, Ireland Thursday, January 30, 2025, 10:00 Hrs [IST] C2 PHARMA, the global leader in manufacturing ...

Shardul Nautiyal, Mumbai Thursday, January 30, 2025, 08:00 Hrs [IST] ...

Kerala, Karnataka & UP report almost 50% of sales of Jan Aushadhi Kendras in five years: Gireesh Babu, New Delhi Thursday, January 30, 2025, 08:00 Hrs [IST] Kerala, Karnataka and ...

Indian healthcare sees AI & VR to reshape how medical treatment is accessed and delivered: Nandita Vijayasimha, Bengaluru Thursday, January 30, 2025, 08:00 Hrs [IST] The Indian he ...

DGFT amends HBP-2023 to implement eCoO system to streamline export documentation process: Shardul Nautiyal, Mumbai Thursday, January 30, 2025, 08:00 Hrs [IST] In a significant mov ...

Dissenting group in TNCDA forms 13 district committees with majority of retailers: Peethaambaran Kunnathoor, Chennai Thursday, January 30, 2025, 08:00 Hrs [IST] Amid the stand-off ...

Indian Pharmaceutical Association- Karnataka State Branch elects Dr M Khalid Khan as president: Our Bureau, Bengaluru ...

Neurocrine Biosciences begins phase 3 registrational study of osavampator as an adjunctive therapy to treat major depressive disorder: San Diego Wednesday, January 29, 2025, 18:00 ...

EMA accepts for review regulatory application of GSK’s Shingrix new prefilled syringe presentation for prevention of shingles: London, UK Wednesday, January 29, 2025, 13:00 Hrs ...

GSK announces depemokimab applications accepted for review in China and Japan for asthma with type 2 inflammation and CRSwNP: London, UK Wednesday, January 29, 2025, 17:00 Hrs [IS ...

Curium introduces innovative 18F-PSMA PET radiopharmaceutical, Pylclari to treat prostate cancer in Estonia, Finland, Latvia, & Sweden: Paris, France Wednesday, January 29, 2025, ...

Beckman Coulter receives US FDA breakthrough device designation for Alzheimer’s disease blood test: Brea, California Wednesday, January 29, 2025, 16:00 Hrs [IST] Beckman Coulter ...